enVVeno Medical Corporation Common Stock

NVNONASDAQUSD
9.81 USD
0.49 (4.76%)AT CLOSE (11:59 AM EDT)
9.55
0.27 (2.70%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
9.55
0.27 (2.70%)
🔴Market: CLOSED
Open?$10.00
High?$10.00
Low?$9.04
Prev. Close?$10.30
Volume?12.6K
Avg. Volume?11.9K
VWAP?$9.79
Rel. Volume?1.05x
Bid / Ask
Bid?$6.92 × 100
Ask?$12.37 × 100
Spread?$5.45
Midpoint?$9.65
Valuation & Ratios
Market Cap?6.5M
Shares Out?667.7K
Float?14.9M
Float %?73.6%
P/E Ratio?N/A
P/B Ratio?0.28
EPS?-$28.18
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Employees
33
Market Cap
6.5M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2018-05-31
Address
70 DOPPLER
IRVINE, CA 92618
Phone: 949-261-2900
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?11.89Strong
Quick Ratio?11.89Strong
Cash Ratio?1.21Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
0.28CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-0.2CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-79.2%WEAK
ROA?
-72.1%WEAK
Cash Flow & Enterprise
FCF?$-14793000
Enterprise Value?$4.0M
Fundamentals ratios updated end of day